CVM Research

Fact-based research on $CVM. We are shareholders of CEL-SCI. We are not affiliate of CEL-SCI and not paid by CEL-SCI. No investment advice.

[CVM Research @CVMResearch1]

https://t.co/bF8AlirEFx CEL-SCI $CVM ASCO Abstracts Reveal a Gold Mine

[CVM Research @CVMResearch1]

https://t.co/loSvz2qmaV $CVM The Science Behind Multikine And Why It Is A Dream Platform for Big Pharmas

[CVM Research @CVMResearch1]

https://t.co/fKADj34owb $CVM FDA's Recent Subgroup Cases Point to Multikine Approval

[CVM Research @CVMResearch1]

@LaugaNico @US_FDA Yes, we are.

[CVM Research @CVMResearch1]

https://t.co/SuFLJDoIAJ be prepared for the press release on pre-BLA meeting between $CVM and the @US_FDA 👇👇

[CVM Research @CVMResearch1]

https://t.co/PqkbWMQBAP Full transcript of $CVM investor call to discuss Phase 3 results: best way to understand the robustness of the study design and the results. 👇👇👇@GeertKersten1
@FrugalNorwegian
@dinhvesting
@ScotchStocks